Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA approves new seven-day treatment for community-acquired pneumonia

Aug. 7, 2001

Vion initiates phase II clinical trials of Triapine for metastatic breast cancer

Aug. 7, 2001

Cell Pathways begins phase II trials of CP-461 in several types of cancer

Aug. 7, 2001

Shire's once-daily treatment for ADHD receives FDA approvable letter

Aug. 7, 2001

YM-471 shows potent affinity and selectivity for human vasopressin V1A and V2 receptors

Aug. 7, 2001

Chronic dronedarone differs strongly from chronic amiodarone in the canine heart

Aug. 7, 2001

Novel benzothiophene HSV-1 inhibitor identified by Pfizer

Aug. 7, 2001

FDA places TP-10 pediatric trials on hold

Aug. 7, 2001

NCI awards Phase I SBIR grant to Kosan Biosciences for anticancer compound

Aug. 7, 2001

PhotoCure applies for approval of photodynamic skin cancer therapy throughout Europe

Aug. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...